New depression drug shows promise in early trial
NCT ID NCT06236880
First seen Feb 17, 2026 · Last updated May 05, 2026 · Updated 12 times
Summary
This study tests a new drug called GM-2505 for people with major depressive disorder. It involves two doses given two weeks apart. The goal is to see if the drug is safe and helps reduce depression symptoms. The study includes 124 adults aged 18 to 65 who are either not on antidepressants or are partial responders to their current medication.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
MAC Clinical Research
RECRUITINGManchester, United Kingdom
Contact
Conditions
Explore the condition pages connected to this study.